Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

42.51
BATS BZX Real-Time Price
As of 12:41pm ET
 -2.09 / -4.69%
Today’s Change
33.50
Today|||52-Week Range
120.96
-34.52%
Year-to-Date
3 Biotech Stocks to Buy Now for the Long Haul
Jun 25 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close44.60
Today’s open44.17
Day’s range41.95 - 44.17
Volume19,990
Average volume (3 months)799,475
Market cap$1.7B
Dividend yield--
Data as of 12:41pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc+0.02+0.06%
NEONeogenomics Inc+0.10+1.25%
GNMKGenMark Diagnostics ...+0.20+2.31%
RDNTRadNet Inc-0.01-0.19%
Data as of 12:40pm ET, 06/30/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.30
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Senior Vice President-Finance &
Contact Person
Glenn Goddard
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs